Kamada (KMDA) EBIT Margin Growth (1y) (2013 - 2026)
Kamada (KMDA) EBIT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Kamada | 461.75 Mn | 432.27 Mn | 22.47 Mn | 152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 152.00 |
| Mar 31, 2026 | -234.00 |
| Dec 31, 2025 | -585.00 |
| Sep 30, 2025 | 274.00 |
| Jun 30, 2025 | 4,228.00 |
| Mar 31, 2025 | 701.00 |
| Dec 31, 2024 | 1,711.00 |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -701.00 |
| Mar 31, 2024 | 976.00 |
| Dec 31, 2023 | -122.00 |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 1,675.00 |
| Mar 31, 2023 | 7.00 |
| Dec 31, 2022 | 1,934.00 |
| Sep 30, 2022 | 1,144.00 |
| Jun 30, 2022 | -1,404.00 |
| Mar 31, 2022 | -1,316.00 |
| Dec 31, 2021 | -2,281.00 |
| Sep 30, 2021 | -2,880.00 |